- Patanjali Foods Ltd reported a net income of 3.71 billion rupees for the third quarter.
- This represents a 71% increase compared to the same period last year.
- The company’s revenue reached 91 billion rupees, marking a 15% growth year-over-year.
- Total costs for the quarter were 86.5 billion rupees, which is a 13% increase from the previous year.
- Raw material costs rose significantly by 21% to 59.8 billion rupees.
- EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for the quarter was 5.81 billion rupees.
- Analyst recommendations include 3 buy ratings, with no holds or sells.
A look at Patanjali Foods Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores for Patanjali Foods, the company appears to have a promising long-term outlook. With strong scores in Momentum and Resilience, the company shows good potential for growth and stability in the market. A moderate score in Dividend indicates a balanced approach to rewarding investors, while Growth suggests a steady expansion of the company’s operations. The Value score, although not the highest, indicates that the company’s stock may be undervalued, presenting a potential opportunity for investors.
Ruchi Soya Industries Limited, the parent company of Patanjali Foods, specializes in the production of soybean oil, vegetable fat, soya protein, and other related products. They have diversified into manufacturing cooking oils as well. With these products in their portfolio, Patanjali Foods under the Ruchi Soya Group’s umbrella could leverage its expertise and resources to tap into the growing demand for healthy food options in the market, potentially driving future growth and profitability for the company.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
